Ginkgo Bioworks Holdings DNA
NYSE DNA
$6.80 -0.14 (-2.09%)
As of: Sep 9, 2026 · 3:59 PM EDT

Ginkgo Bioworks Holdings (DNA) Interest Coverage Ratio Growth (3y) (2023 - 2024)

Analysis

Ginkgo Bioworks Holdings (DNA) Interest Coverage Ratio Growth (3y) (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover Growth (3y) (Qtr)
1 Iqvia Holdings 44.06 Bn 42.11 Bn 1.44 Bn -6.08%
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn -
3 Charles River Laboratories International 13.77 Bn 13.62 Bn 452.07 Mn -5.66%
4 Icon 12.62 Bn 11.69 Bn 479.29 Mn 4.35%
5 Fortrea Holdings 1.68 Bn 1.51 Bn 139.20 Mn -
6 Evotec SE 661.34 Mn 235.46 Mn - -
7 Ginkgo Bioworks Holdings 442.79 Mn 358.26 Mn 18.44 Mn -
8 Champions Oncology 72.49 Mn 72.62 Mn 7.03 Mn -
9 MindWalk Holdings 61.66 Mn 53.38 Mn 1.82 Mn -56.69%
10 VivoSim Labs 1.47 Mn 1.47 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 89.74%
Sep 30, 2024 28.97%
Dec 31, 2023 65.04%
Sep 30, 2023 32.53%